Trial Profile
The Value of Preemptive Dexmedetomidine Transversus Abdominis Plane (TAP) Block in Patients Undergoing Elective Cesarean Section Under General Anesthesia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Dec 2014
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Pharmacodynamics
- 15 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jul 2014 New trial record